PAMS
SRNE

Pictet Asset Management (Switzerland)’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-62,693
Closed -$56K – 2061
2022
Q4 		$56K Buy
62,693
+43,627
+229% +$57.9K ﹤0.01% 1957
2022
Q3 		$30K Hold
19,066
– – ﹤0.01% 1546
2022
Q2 		$38K Hold
19,066
– – ﹤0.01% 1551
2022
Q1 		$44K Hold
19,066
– – ﹤0.01% 1662
2021
Q4 		$89K Hold
19,066
– – ﹤0.01% 1664
2021
Q3 		$145K Buy
+19,066
New +$162K ﹤0.01% 1654

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s SRNE Position: Q1 2023 in Review

Pictet Asset Management (Switzerland) sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 62,693 shares — an estimated $56K sold.

Pictet Asset Management (Switzerland) first reported a position in SRNE in Q3 2021 and held it in 6 quarters. The position peaked at $145K in Q3 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Pictet Asset Management (Switzerland) reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Pictet Asset Management (Switzerland) sold 62,693 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $56K.
  • Pictet Asset Management (Switzerland) first reported a position in Sorrento Therapeutics, Inc. in Q3 2021 and held it in 6 quarters.
  • Pictet Asset Management (Switzerland)'s Sorrento Therapeutics, Inc. position peaked at $145K in Q3 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q1 2023, filed 10 May 2023.